Oshiri
As Gary has stated on a number of occasions, this is also his and Management's preferred option as well (ie TSN to acquire CX's shares in TSI). I am confident that the original deal with CX Partners will have provided TSN with an option to do this and I suspect that this is currently being worked on. Price/cost of the shares will be the only potential issue IMO .... however I reckon we will at least increase our holding to over 50% within the next few months. Once this occurs the disclosure issues will be removed and everyone will realise how much has been achieved to date in terms of profitability and cash flow.
My sentiment remains unchanged but I am happy to see the down ramping / scare mongering continue as it is providing opportunities I never thought I would have again to acquire at these levels
MartyW
- Forums
- ASX - By Stock
- VOR
- Ask Q directly to Ceo (gary froster) and post here
Ask Q directly to Ceo (gary froster) and post here, page-31
-
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VOR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online